Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
27 /100
MEDIUM RISK
Score updated Oct 13, 2026

CADL — Candel Therapeutics, Inc. Dilution Risk Tracker

Track CADL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CADL — Get alerts when the score changes →

As of October 13, 2026, Candel Therapeutics, Inc. (CADL) has a DilutionWatch DilutionScore of 27/100, rated MEDIUM dilution risk. Candel Therapeutics, Inc. has a market capitalization of $748.35M, 76.52M shares outstanding, 115 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $100.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $100M remaining capacity
🔔 Track CADL — Get forecast alerts →

Market Data

Market Cap$748.35M
Shares Outstanding76.52M
Float56.91M
Cash$201.56M
Debt$1.73M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore27/100DilutionWatch score record
Shares Outstanding76.52MVerified float table or market cache
Public Float56.91MVerified float table or market cache
Market Cap$748.35MMarket data cache
Cash Runway52.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$100.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 4, 8-K 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 95.6% shares (2026Q1 vs prior)
115 institutional holders · 47.20M shares
#1 FMR LLC 10.99M shares
#2 RTW INVESTMENTS, LP 6.42M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 4.93M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest13.00M
Days to Cover11.2
% of Float22.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-12
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-02-26
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CADL Dilution Snapshot

Candel Therapeutics, Inc. (CADL) has a DilutionScore of 27/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CADL's DilutionScore is currently 27/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 30/100 (Medium risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202627/100MEDIUM60 days
Jul 16 – Aug 13, 202630/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CADL shares outstanding have increased 0.0% from 73.25M (Mar 2026) to 73.27M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202673.27M56.91M▼ 10.14%
May 15, 202673.27M63.33M▲ 0.03%
Mar 13, 202673.25M63.31M▲ 33.42%
Mar 09, 202673.25M47.45M▼ 0.86%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CADL Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CADL files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CADL — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CADL
CADL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.